Companies: 48,874 Total Market Cap: 132391982605079.18

Bausch Health Companies

NYSE: BHC
Healthcare Drug Manufacturers - Specialty & Generic
Rank #6609
Market Cap 1.71 B
Volume 558,246
Price 4.64
Change (%) 0.64%
Country or region Canada Canada

Bausch Health Companies's latest marketcap:

1.71 B

As of 05/19/2025, Bausch Health Companies's market capitalization has reached $1.71 B. According to our data, Bausch Health Companies is the 6609th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.71 B
Revenue (ttm) 9.73 B
Net Income (ttm) -40,000,000
Shares Out 369.55 M
EPS (ttm) -0.11
Forward PE 1.12
Ex-Dividend Date n/a
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/19/2025

Bausch Health Companies's yearly market capitalization.

Bausch Health Companies has seen its market value grow from $1.01 B to $1.71 B since 1998, representing a total increase of 70.09% and an annual compound growth rate (CAGR) of 2.03%.
Date Market Cap Change (%)
05/19/2025 $1.71 B -41.41%
12/31/2024 $2.96 B 1.22%
12/29/2023 $2.93 B 28.88%
12/30/2022 $2.27 B -77.09%
12/31/2021 $9.92 B 34.3%
12/31/2020 $7.39 B -29.94%
12/31/2019 $10.54 B 63.22%
12/31/2018 $6.46 B -10.81%
12/29/2017 $7.24 B 43.49%
12/30/2016 $5.05 B -85.53%
12/31/2015 $34.88 B -27.4%
12/31/2014 $48.04 B 22.55%
12/31/2013 $39.20 B 115.15%
12/31/2012 $18.22 B 26.73%
12/30/2011 $14.38 B 69.4%
12/31/2010 $8.49 B 284.24%
12/31/2009 $2.21 B 45.15%
12/31/2008 $1.52 B -29.54%
12/31/2007 $2.16 B -36.05%
12/29/2006 $3.38 B -10.72%
12/30/2005 $3.78 B 44.09%
12/31/2004 $2.62 B -22.75%
12/31/2003 $3.40 B -18.31%
12/31/2002 $4.16 B -43.75%
12/31/2001 $7.39 B 53.06%
12/29/2000 $4.83 B 107.29%
12/31/1999 $2.33 B 131.21%
12/31/1998 $1.01 B

Company Profile

Bausch Health Companies Inc. Overview

Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets a wide range of products across multiple therapeutic areas. The company operates globally, with a focus on gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

Business Segments

  • Salix: Specializes in gastroenterology products.
  • International: Markets aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products.
  • Solta Medical: Focuses on the sale of aesthetic medical devices.
  • Diversified: Offers pharmaceutical products in neurology, dermatology, generic pharmaceuticals, and dentistry.
  • Bausch + Lomb: Provides vision care, surgical, and ophthalmic pharmaceutical products.

Corporate Background

Formerly known as Valeant Pharmaceuticals International, Inc., the company rebranded as Bausch Health Companies Inc. in July 2018. It is headquartered in Laval, Canada.

Frequently Asked Questions

As of 05/19/2025, Bausch Health Companies (including the parent company, if applicable) has an estimated market capitalization of $1.71 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Bausch Health Companies global market capitalization ranking is approximately 6609 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Canada
Founded 0
IPO Date n/a
Employees 20,700
CEO Thomas Appio
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
Website https://www.bauschhealth.com
People Also Watch
Zoetis
163.90 0.64%
Merck KGaA
129.22 0.64%
Haleon plc
541.90 0.64%
NSE-SUNPHARMA
20.24 0.64%